michigan semaglutide gastric stasis lawyer kentucky law firm glp-1 in Glucagon-like peptide-1 receptor agonists and muscle mass effects kentucky glp-1 gastric stasis attorney – michigan semaglutide gastric stasis law

Mounjaro and Ozempic are designed to be taken long-termand sometimes indefinitelyto maintain blood sugar and weight loss results

Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, alleging the drugmaker failed to report potential side effects in patients who took the popular GLP-1 medications in a timely manner

Clinical evidence suggests weight regain may potentially occur if the medication is stopped, reinforcing the need to adhere to long-term lifestyle changes directed by your doctor

Rather than combining Wegovy with unproven supplements, patients seeking to optimise weight management outcomes should focus on evidence-based strategies that complement pharmacological treatment

Important additional risks include diabetic retinopathy complications (particularly in patients with pre-existing retinopathy or rapid improvement in blood glucose), gallbladder disease (such as gallstones), and kidney problems related to dehydration from persistent vomiting or diarrhoea